Document is current
Any future updates will be listed below
-
Authors
Cornelius, Victoria https://orcid.org/0000-0002-0080-1065
Wilson, Rosemary
Cro, Suzie
Barker, Jonathan
Burden, David
Griffiths, Christopher E. M.
Lachmann, Helen
McAteer, Helen
Reynolds, Nick
Pink, Andrew
Warren, Richard B.
Capon, Francesca
Smith, Catherine
-
Funding
Funding for this research was provided by:
Efficacy and Mechanism Evaluation Programme (13/50/17)
- License Information
-
More Information
Article History
Received: 20 September 2017
Accepted: 4 August 2018
First Online: 29 August 2018
Ethics approval and consent to participate
: This protocol and study have been approved by the London Dulwich Research Ethics Committee (reference 15/LO/0436), the Health Research Authority (reference 162093) and the MHRA for clinical trial authorisation (reference 11387/0026/001). Informed written consent will be obtained from all participants prior to recruitment to the study.
: AP has received honoraria from Novartis, Almirall, LEO Pharma and La Roche-Posay. FC has received funding from Boehringer Ingelheim. CEMG has received honoraria and/or research grants from AbbVie, Almirall, Boehringer Ingelheim, Celgene, Janssen, LEO Pharma, Novartis, Pfizer, Sandoz and UCB Pharma. All of the other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
